Egypt's Minister of Health and Population Khaled Abdel Ghaffar met Kazakhstan's ambassador to Egypt, Askar Zhenis, to discuss strengthening bilateral cooperation in healthcare and pharmaceutical manufacturing technology. Abdel Ghaffar emphasized Egypt's interest in expanding ties through the transfer of pharmaceutical manufacturing technologies and harmonizing Good Manufacturing Practice standards. The talks covered collaboration in pharmaceutical production, biotechnology, and public health initiatives.
On January 14, 2026, Egypt's Minister of Health and Population Khaled Abdel Ghaffar met with Askar Zhenis, Kazakhstan's ambassador to Egypt, to explore ways to bolster bilateral ties in healthcare. According to a ministry statement, Abdel Ghaffar highlighted Egypt's eagerness to deepen cooperation via the transfer of pharmaceutical manufacturing technologies, aligning Good Manufacturing Practice (GMP) standards, and unlocking new trade and investment pathways between the nations.
The discussions centered on joint efforts in pharmaceutical production, biotechnology, research and development, capacity building, vaccination programs, and wider public health endeavors. They also addressed prospects for increasing Egyptian pharmaceutical exports, such as hepatitis C treatments and products from the Egyptian International Pharmaceutical Industries Company (EIPICO).
The meeting assessed ongoing joint initiatives, including co-production deals, technology transfers, and research on vaccines and biological products, leveraging Egypt's expertise in pharmaceutical manufacturing and public health. Abdel Ghaffar issued a formal invitation to Kazakhstan's health minister to visit Egypt, tour hospitals and production facilities, and identify investment opportunities to strengthen healthcare sectors in both countries.